Streetbeat News

Analyst Ratings

ADBE

Adobe Inc.'s stock is currently trading at $487.94, marking a 1.38% increase. Over the past month, the stock has increased by 7.47%, and by 27.01% over the past year. Adobe's P/E ratio is lower than the aggregate P/E of the Software industry, which could indicate that the stock is undervalued or that shareholders do not expect future growth.

Portfolio Pulse from Benzinga Insights

July 07, 2023 | 7:16 pm

XPEV

XPeng (NYSE:XPEV) has received mixed ratings from analysts in the last quarter, with 1 somewhat bullish, 3 indifferent, 1 somewhat bearish, and 1 bearish. The average price target is $10.07, implying a downside from the current price of $14.26. This average has increased by 17.09% from the previous average price target of $8.60.

Portfolio Pulse from Benzinga Insights

July 07, 2023 | 7:01 pm

MTH

Over the past 3 months, 6 analysts have published their opinion on Meritage Homes (NYSE:MTH) stock. The analysts have an average price target of $197.17 versus the current price of Meritage Homes at $132.51, implying upside. This current average has increased by 50.89% from the previous average price target of $130.67.

Portfolio Pulse from Benzinga Insights

July 07, 2023 | 7:01 pm

ACN

Accenture (NYSE:ACN) has received various analyst ratings in the last quarter, with 7 bullish, 4 somewhat bullish, and 7 indifferent. The average 12-month price target for Accenture, according to 18 analysts, is $338.67, which has increased by 6.88% over the past month.

Portfolio Pulse from Benzinga Insights

July 07, 2023 | 7:01 pm

NVDA

In the last quarter, 48 analysts have provided ratings for NVIDIA (NASDAQ:NVDA), with a majority being bullish or somewhat bullish. The company has an average 12-month price target of $429.52, with a high of $600.00 and a low of $290.00. This average price target has increased by 39.17% over the past month.

Portfolio Pulse from Benzinga Insights

July 07, 2023 | 7:01 pm

MOH

Over the past three months, 10 analysts have published their opinions on Molina Healthcare (NYSE:MOH) stock. The average price target for the stock is $340.9, representing a 2.92% decrease from the previous average price target of $351.14.

Portfolio Pulse from Benzinga Insights

July 07, 2023 | 7:01 pm

CSTL

Over the past 3 months, 12 analysts have published their opinion on Castle Biosciences (NASDAQ:CSTL) stock. The company has an average price target of $34.83, a decrease of 21.73% from the previous average price target of $44.50. The majority of the analysts are bullish on the stock.

Portfolio Pulse from Benzinga Insights

July 07, 2023 | 7:00 pm

KRUS

Stephens analyst Joshua Long reiterated an Overweight rating on Kura Sushi USA, Inc. (NASDAQ:KRUS), raising the price target to $95 from $85. The company's 3Q23 results were in line with revenue expectations and ahead on restaurant-level margins, EBITDA, and EPS. The analyst raised FY23E top-line estimate from $187.7 million to $188.0 million, driven by top-line strength and new unit development. KRUS shares are trading higher by 17.85% to $100.47.

Portfolio Pulse from Nabaparna Bhattacharya

July 07, 2023 | 7:00 pm

SLP

Oppenheimer analyst Francois Brisebois reiterated an Outperform rating on Simulations Plus, Inc. (NASDAQ:SLP) with a price target of $67. Brisebois sees SLP as an attractive investment for exposure to biotech innovation themes and data growth waves. The analyst is optimistic about SLP's 10-year growth trajectory and cash position. SLP reported 3Q23 with a top line of $16.2 million, mostly in line with estimates. The company's software revenue was $10.6 million. The analyst expects FY23 revenues of $60.67 million, up 12.6% Y/Y, and EPS of $0.64, up from $0.60 a year ago.

Portfolio Pulse from Nabaparna Bhattacharya

July 07, 2023 | 6:47 pm

ACGL

Arch Capital Group Inc.'s (NASDAQ:ACGL) stock has increased by 5.12% over the past month and by 68.42% over the past year. Despite this, its P/E ratio is lower than the aggregate P/E of the insurance industry, suggesting it might be undervalued. However, investors are advised to use the P/E ratio cautiously and in conjunction with other financial metrics and industry trends.

Portfolio Pulse from Benzinga Insights

July 07, 2023 | 6:46 pm